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Summary 
Experimental data suggest hat negative selection of thymocytes can occur as a result of su- 
praoptimal antigenic stimulation. It is unknown, however, whether such mechanisms are at 
work in mature CD8 + T lymphocytes. Here, we show that CD8 + effector cytotoxic T lym- 
phocytes (CTL) are susceptible to proliferative inhibition by high dose peptide antigen, leading 
to apoptotic death mediated by TNF-ci release. Such inhibition is not reflected in the cytolytic 
potential of the CTL, since concentrations of antigen that are inhibitory for proliferation pro- 
mote efficient lysis of target cells. Thus, although CTL have committed to the apoptotic path- 
way, the kinetics of this process are such that CTL function can occur before death of the 
CTL. The concentration f antigen required for inhibition is a function of the CTL avidity, in 
that concentrations of antigen capable of completely inhibiting high avidity CTL maximally 
stimulate low avidity CTL. Importantly, the inhibition can be detected in both activated and 
resting CTL. Blocking studies demonstrate hat the CD8 molecule contributes significantly to 
the inhibitory signal as the addition of anti-CD8 antibody restores the proliferative response. 
Thus, our data support he model that mature CD8 + CTL can accommodate anactivation sig- 
nal of restricted intensity, which, if surpassed, results in deletion of that cell. 
T he induction and maintenance of tolerance has been shown to significantly limit the potentially deleterious 
responses of self-reactive T lymphocytes. Although thymic 
education is thought o contribute significantly to the erad- 
ication of self-reactive T cells (1, 2), the induction of toler- 
ance via peripheral exposure to antigen has been well doc- 
umented (3-9). Deletion and/or inactivation of peripheral, 
antigen-reactive T lymphocytes has been observed in a 
number of experimental systems, including oral administra- 
tion of antigen (10), repeated immunization with antigen 
(9), exposure to superantigens (8), and tissue-specific ex- 
pression of antigens (5, 11). In addition, a recent report of 
clonal exhaustion has demonstrated the selective deletion 
of virus-specific T cells after challenge with high doses of 
virus (12). This result adds to a growing body of literature 
that examines the induction of tolerance in the presence of 
high doses of antigen. Several mechanisms have been pos- 
tulated to explain this phenomenon i cluding downregula- 
tion of cell-surface receptors leading to anergy (7, 11) and 
deletion of reactive cells (7, 8, 12). 
The induction of peripheral tolerance via administration 
of high doses of antigen is poorly understood. In vitro data 
investigating the role of high concentrations of antigen on 
the regulation of resting CD4 + T lymphocytes have dem- 
onstrated a suppression of the proliferative response and in- 
duction of anergy in CD4 + T cell clones when exposed to 
supraoptimal ntigen doses (13). More recent data from 
Lenardo and collaborators using TCk  transgenic animals 
specific for a myelin basic protein (MBP) I peptide, Acl-11, 
demonstrated CD4 + T cell deletion as a result ofsupraopti- 
mal peptide/MHC stimulation (14). Transfer of CD4 + 
cells from the transgenic mice into nontransgenic mice in- 
duced experimental llergic encephalomyelitis n the recip- 
ient animal. However, recipient mice treated with high 
doses of MBP peptide did not develop experimental ler- 
gic encephalomyelitis. In vitro studies showed that such 
high antigen conditions resulted in the deletion of recently 
activated cycling MBP-reactive T cells via activation- 
induced cell death (AICD), thereby establishing tolerance. 
AICD is thought o result from reexposure of cycling T 
IAbbreviations used in this paper: AICD, activation-induced lldeath; 
MBP, myelin basic protein. 
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lymphocytes to antigen (14). Mthough characterized pri- 
marily in CD4 + T cells, AICD has also been observed in 
bulk lymph node CD8 + T cells stimulated with anti-CD3 
(15), but not in CTL lines of defined epitope specificity. 
Previously, we have demonstrated that CD8 + CTL lines 
of differing avidity can be selected by varying the peptide/ 
MHC determinant density on APC (16). In this system, se- 
lection of low avidity CTL lines by high determinant den- 
sity should be possible only if high avidi W CTL are being 
actively deleted. In the current report, we have investigated 
the effect of high dose antigen on CTL of differing avidities 
to define parameters giving rise to negative selection in ma- 
ture, peripheral CD8 + effector T lymphocytes. Classically, 
the functional consequence of TCR engagement by CD8 + 
CTL has been evaluated by the lysis of appropriate target 
cells, and under these circumstances, high dose inhibition 
has not been observed (17). As little is known about the ef- 
fects of stimulation with supraoptimal ntigen on the pro- 
liferative response of either resting or cycling CD8 + CTL, 
CTL lines of either high or low avidity (as measured by 
their dose response curve to peptide antigen) were exam- 
ined for their proliferative response to APC pulsed with a 
range of peptide concentrations. The data presented herein 
demonstrate hat CD8 + CTL can undergo inhibition and 
cell death in a peptide specific and dose titratable manner, 
mediated at least in part by the release of TNF-ot, but not 
by Fas. In addition, the susceptibility of CTL to inhibition 
at any given peptide concentration is dependent on the 
avidity of those CTL. Importantly, the observed inhibition 
appears to be independent of the initial activation state of 
the CTL, and is set in motion even in resting CTL within 
the first 9 h of stimulation, in contrast to AICD in CD4 + T 
cells. Thus, CD8 + CTL, depending on their avidity, are 
susceptible to negative regulation in the periphery by su- 
praoptimal peptide/MHC determinant density on APC. 
Materials and Methods 
Mice and Antibodies. BALB/c mice were purchased from Jack- 
son Laboratories (Bar Harbor, ME). Anti-CD8ot antibody (clone 
53-6.7), Jo2 anti-fas antibody, and FcBlock were purchased from 
Pharmingen (San Diego, CA). Neutralizing anti-TNF-o~ poly- 
clonal antiserum was purchased from Genzyme (Cambridge, MA). 
Activity of the anti-Fas antibody to inhibit Fas-Fas ligand interac- 
tion was measured as described (18; see legend to Fig. 4). 
Peptides. Peptides were synthesized on an automated peptide 
synthesizer (model 430A; Applied Biosystems, Inc., Foster City, 
CA) using t-boc chemistry (19). The peptides were cleaved from 
the resin with HF and initially purified by size exclusion chroma- 
tography (P4 Biogel; Bio-Rad Laboratories, Mountain View, CA). 
Purification to single peaks was achieved by reverse-phase HPLC 
on Ixbondapack reverse-phase C18 analytical and preparative 
columns (Waters Associates, Milford, PA). I10 (RGPGRAFVTI) 
is the imnmnodominant epitope from gp160 in BALB/c mice 
(20-22). 
Generation of CTL  Lines. 7.5 • 1if' responding BALB/c spleen 
cells from mice previously immunized with a recombinant vac- 
cinia expressing the gp16%m protein from H1V-1 were cocul- 
tured with 3.5 • 10 (' stimulating BALB/c splenocytes (3,000 rad) 
pulsed with various concentrations (100, 0.1, or 0.0001 I~M) of 
I10 peptide or in the presence of 1 jaM free peptide in a 24-well 
plate containing 2 ml of a 1:1 mixture of RPMI 1640 and Eagle 
Hank's amino acid (EHAA) medium supplemented with 
t-glutamine, sodium pyruvate, nonessential mino acids, penicil- 
lin, streptomycin, 5 • 10 -s M [3-mercaptoethanol, 10% FCS, and 
10% T-stim (Collaborative Biomedical Products, Bedford, MA). 
CTL lines were established from primary cultures and were main- 
tained by weekly restimulation of 3-5 • l0 s cells/well in the 
presence of 5 • lff' irradiated (3,000 rad) BALB/c spleen cells 
pulsed with the appropriate concentration f I 10 peptide. 
r The S~Cr elease assay was carried out as 
previously described (23). 10 t' target cells were labeled with 301) ~Ci 
ofNa 2 SlCrO4 in 200-250 p,1 for 2 h at 37~ In some cases, tar- 
gets were pulsed with 10 p,M peptide during labeling. Cells were 
then washed three times and added at 3,000 cells/well along with 
the appropriate number ofeffector cells in 96-well round-bottom 
plates. In some cases, peptide was added directly in the CTL assay 
in the absence of previous pulsing. After 4 h, supernatants were 
harvested and counted in an Isomedic gamma counter (ICN, 
Horsham, PA). The mean of the triplicate samples was calculated, 
and the percent of SlCr release was calculated according to the 
following equation: 
percent specific 51Cr release = 10() X [(experimental 51Cr release -
control 51Cr re#ase) / (maximum 5t Cr release - control s l Cr wlease) ],
where experimental SICr release represents counts from target 
cells mixed with effector cells, control 51Cr release represents ar- 
get cells mixed with medium alone (spontaneous release), and 
maxinmm 51Cr release represents counts from target cells exposed 
to 2.5% Triton X-100. 
Proliferation Assays. CTL (day 4 [d41 or dl I after stinmlation) 
were plated at 5 • 10a/well in a 96-well round bottom microti- 
ter plate. Where appropriate, anti-CD8 antibody was added and 
plates incubated at 37~ for 15 rain. After this incubation, irradi- 
ated (3,000 rad) BALB/c splenocytes previously pulsed with 110 
peptide and washed three times were added at 3 • 10S/well. Su- 
pernatant from the final wash ofstinmlators pulsed with 100 I.zM 
I10 peptide was reserved and added to wells with I).001 ixM- 
pulsed stinmlators at a final dilution of 1:1 to ensure that effects 
seen with 100 b~M-pulsed stimulators was not caused by residual, 
free I10 peptide that could bind the CTL directly. In some cases, 
Jo2 anti-Fas (10 Ixg/ml) in combination with FcBlock (5 b~g/ml), 
both from Pharmingen, or anti-TNF-c~ (1:50) antibodies (Gen- 
zyme) were used. FcBlock was added to prevent possible cross- 
linking of anti-Fas by APC. Proliferation was measured by addi- 
tion of 1 txCi [3H]thymidine/well at 0, 24, or 48 h, and plates 
were harvested at 24, 48, or 72 h, respectively. Results obtained 
at all harvest times were qualitatively sinfilar. Results are the geo- 
metric mean of triplicate cultures. 
Apoptotic Death Assays. CTL were enriched by centrifuging 
lines over Ficoll. After washing, 1 if' CTL were added along with 
5 • 10 (' peptide-pulsed stimulators (depleted of Thy 1.2 + cells) in 
2 nfl of medium, containing 10% T-stim as a source of IL-2, per 
well of a 24-well plate. After 46 b, cells were harvested and incu- 
bated with biotin-conjugated Thy 1.2 mAb, followed by PE-avi- 
din or FITC-conjugated Thy 1.2 to identify CTL, washed, resus- 
pended in 50% FCS in PBS, and penneabilized by addition of 
three parts 70% EtOH. After overnight fixation at 4~ cells in- 
cubated with Thy 1.2-biotin and PE-avidin were washed with 
cold PBS and incubated for 30 nfin with 5 btg/ml Hoechst 33342 
(Molecular Probes, Inc., Eugene, OR) at 37~ Cells were then 
centrifuged, and the pellet was resuspended in 21) bL1 PBS. Apop- 
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totic nuclei were identified by fluorescent microscopy (24). Al- 
ternatively, EtOH fixed cells were washed and incubated with 
R.NAse A for 30 rain at 37~ followed by addition ofpropidium 
iodide (25). Cells were analyzed on a FACSort | (Becton Dickin- 
son & Co., Mountain View, CA). The percentage of Thy 1.2 + 
cells with hypodiploid DNA was used as a measure of apoptotic 
death as in (25). 
Resu l ts  
CTL  Lines with Distinct Avidities Are Differentially Inhibited 
by ,Stimulators Presenting High Dose Antigen. CTL lines were 
generated by stimulation with splenocytes pulsed with ei- 
ther high dose (100 I~M) or low dose antigen (0.0001 lxM) 
(16). The two lines are distinct in their determinant density 
requirements for both proliferation (Fig. 1 A) and CTL 1y- 
sis, and are stable in their respective phenotype (16). The 
concentration ofpept ide antigen required for optimal pro- 
liferation varied by nearly 1,000-fold between the high and 
low avidity lines (Fig. 1 A). CTL were tested on d4 after 
routine stimulation and assays were done in the presence of  
10% T-stim as a source of  IL-2, as required for proliferation 
by CD8 + cells in response to antigen. Fig. 1 A shows that 
in the presence o fAPC prepulsed with 100 ~M I10 pep- 
tide, the higher avidity CTL (generated on 0.0001 IxM- 
pulsed stimulators) were completely inhibited in their pro- 
liferative response. The inhibition was CD8 dependent, 
since proliferation could be at least partially restored by the 
inclusion o fant i -CD8 antibody (Fig. 1 /3). Further, the res- 
toration was dose dependent in that decreasing amounts of  
anti -CD8 antibody had a diminishing ability to block the 
inhibition. The elegant interplay of  CD8 with TCR recep- 
tor signaling is evident in the contribution by anti -CD8 at 
doses of  antigen that are optimal for activation, as measured 
by proliferation (e.g., 0.001 I~M), where the presence of  
anti -CD8 antibody now blocks proliferation by up to 40%. 
Thus, the contribution of  CD8 enhances either inhibition 
or activation of  the CTL, depending on the amount of  an- 
tigen present on the stimulator. In contrast to the high 
avidity line, the low avidity line is not susceptible to inhibi- 
tion by the same high antigen dose (Fig. 1 A). In fact, con- 
centrations of  peptide antigen that are inhibitory for the 
high avidity line promote optimal proliferation of  the low 
avidity line. Furthermore, proliferation of this line at all 
peptide doses, even 100 p,M, is susceptible to blocking by 
anti -CD8 antibody (Fig. 1 B). 
To interpret he data, it is important o determine that 
the inhibition observed for the high avidity line is not 
caused by residual free peptide in the cells pulsed with high 
dose antigen, which can then bind to and be presented by 
MHC molecules on the CTL. Such inhibition by self-pre- 
sentation of  peptide has been shown, in some cases, to re- 
sult in CTL fratricide, suicide, or anergy (26-30). The in- 
ability of  supernatant from the final wash of  the 100 or 10 
p~M-pnlsed cells to cause inhibition when added to wells 
containing 0.001 p~M I10-pulsed stimulators shows that the 
inhibition is caused solely by presentation of  the relevant 
A 3~00 15000 
9 9000 
,15000 ~- -# /  9  \ 6000 , 
~ioooo m~m__m~m/ 
o 3000 5OO0 
o 
None -4 -3 -2 -1 0 1 2 
Log I~Molar Concentration of 110 
500 
B 
400 
0;, o~ 
300 
O. 
200 
100 
o~ 
0 
High avidity line 
L_ 
Low avidity line 
-lOO 
None -3 -1 1 2 None -2 1 2 
Log I~M I10 Concentration 
Figure 1. The d4 high avidity line is inhibited in its proliferative r - 
sponse to APC pulsed with high concentrations ofpeptide, and this inhi- 
bition can be reversed by anti-CD8 antibody. (A) The high and low avid- 
ity CTL lines were assayed for proliferation on day 4 after routine 
stimulation. CTL were stimulated with APC pulsed with various concen- 
trations ofpeptide. Cultures were pulsed with [3H]thymidine at 48 h and 
harvested at72 h. APC pulsed with 100 or 10 p,M peptide inhibited pro- 
liferation of the high avidity line (circle) while maximally stimulating the 
low avidity line (squares). As a control for residual free peptide, superna- 
tant from the final wash of the 100 and 10 p,M-pulsed APC was added at 
1:1 dilution into wells with 0.001 b~M-pulsed APC. Counts from addi- 
tion of the 100 I, tM-pulsed APC wash were 9,174 -+ 270 and from the 
10 ~M-pulsed wash APC were 9,982 + 409, i.e., no inhibition relative 
to wells in the absence of the wash supernatant. (B)The addition of solu- 
ble anti-CD8 antibody partially restored the proliferative r sponse of the 
high avidity line while blocking the response of the low avidity line. An- 
tibody was added at four concentrations: 20 Ixg/ml (solid bars), 5 lig/nfl 
(striped bars), 1.3 ~g/ml (stippled bars), and 0.32 ~g/ml (cross-hatched bars). 
The percentage ofshift in response was calculated as 100x (cpm in the 
presence ofanti-CD8 - cpm in the absence ofanti-CD8)/cpm in the ab- 
sence of anti-CD8. 
peptide ligand on APC and not to residual free peptide (see 
figure legend). 
To ensure that the lack of  response observed with high 
dose antigen was not the result of  very early proliferation 
that was complete by the time of  pulsing with [3H]thymi- 
dine, a kinetic experiment was performed. Inhibition by 
high dose antigen was observed even during the 0-24-h 
period (data not shown). This suggests that the inhibition 
observed was not the result of  a shift in the kinetics of  
DNA synthesis relative to the time of  the pulse, but in- 
stead, is a relatively immediate arrest of  the proliferative re- 
sponse of  the high avidity CTL. 
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Inhibition by High Dose Antigen Does Not Depend on Recent 
Activation of the CTL. Previous studies have demonstrated 
the importance of cell cychng for cell death resulting from 
exposure to high dose antigen (14) or high concentrations 
of ant i -TCR antibody (31, 32). Thus, the high and low 
avidity lines were analyzed for susceptibility to high dose 
inhibition at a time point when they should not be actively 
cycling (dl l  after routine stimulation). As observed with 
activated 4 CTL, the high avidity resting CTL were unre- 
sponsive to stimulators pulsed with high dose antigen (100 
and 10 ~M) (Fig. 2 A). Furthermore, the presence ofant i -  
CD8 antibody could relieve the inhibition and allow for 
antigen-specific proliferation (Fig. 2 B). Again, in agree- 
ment with results obtained with d4 CTL, the low avidity 
CTL line was maximally stimulated by APC pulsed with 
high dose antigen (100 and 10 p.M), and the proliferation 
was dependent on CD8 interaction at all peptide concen- 
trations tested (Fig. 2, A and B). Thus, we find that CD8 + 
CTL are susceptible to high dose inhibition independent of 
recent activation and cell cycling. 
High Dose Peptide Antigen Induces Apoptotic Death of the 
CTL. The observed inhibition of the proliferative re- 
sponse to high dose antigen could be the result either of 
A 3O000 
25000 
20000 
Eo.15000 
o 
10000 
500O 
0 
V" :/._./'2.._. 
I I I I I I I I 
None -4 -3 -2 -1 0 1 2 
Log gMo~r Concentration of110 
500 
B 
4O0 
o) 
o~ 
g 300 
Q. 
8 
200 ._E 
100 
o~ 
0 
-100 
Figure 2. 
High avidity line 
l 
Low avidity line 
None -3 -1 t 2 None -2 1 2 
Log ~M 110 Concentration 
Resting dl 1 high avidity CTL are inhibited in the their pro- 
liferative response to high dose antigen. (A) The high and low avidity 
CTL lines that were dl 1 after outine stimulation were tested as described 
in Fig. 1. Both activated (Fig. 1) and resting high avidity CTL were sus- 
ceptible to high dose inhibition. (B) As with d4 high avidity CTL, anti- 
CD8 antibody allowed response to high dose antigen by dl 1 CTL. Per- 
centage of shift in response was calculated asdescribed in Fig. 1. 
anergy or cell death. To determine the mechanism of  the 
reduction in the proliferative response of high avidity CTL, 
lines were stimulated with 0.001 or 100 I-tM peptide- 
pulsed splenocytes depleted of  Thy 1.2 + cells. Depleted 
stimulators were required for discrimination of CTL during 
analysis. 45 h after stimulation, cultures were harvested, in- 
cubated with biotinylated anti-Thy 1.2 Ab followed by 
PE-avidin (to detect CTL), and fixed overnight. Samples 
were then incubated with Hoechst 33342 nuclear stain. 
When viewed by fluorescence microscopy, CTL could be 
distinguished from APC by red membrane staining. The 
number of CTL with apoptotic nuclei, known to exhibit 
specific morphological changes including condensation of 
DNA, could then be quantitated. Fig. 3 A shows that high 
avidity CTL stimulated with APC pulsed with 100 txM 
peptide are undergoing significant apoptosis compared with 
CTL stimulated with 0.001 IxM-putsed APC (47 vs. 3%). 
No apoptotic death was observed with the low avidity line 
under identical conditions (Fig. 3 A), although both high 
and low avidity lines were susceptible to apoptotic deletion 
using high concentrations of  immobilized anti-CD3 anti- 
body (data not shown). Results similar to those observed 
with d4 CTL were obtained with CTL that were 11 d after 
routine stimulation exposed to APC pulsed with high ver- 
sus low concentrations of antigen (data not shown). Thus, 
regardless of the activation state of  the CTL, the result of  
exposure to high dose antigen is identical and occurs with 
the same kinetics. In addition to this analysis, CTL under- 
going apoptotic death were quantitated by hypodiploid 
DNA analysis. Results from these analyses were in agree- 
ment with results obtained by Hoechst analysis (Fig. 3 B). 
Apoptotic death of the CTL line was found to correlate 
with inhibition of proliferation. 
When tested for cytolytic activity, high avidity CTL could 
readily lyse target cells pulsed with high concentrations of 
peptide (data not shown). As shown above, however, these 
concentrations ofpeptide cause inhibition and death. These 
two events can be reconciled by examining the kinetics of 
death. Apoptotic nuclei are not evident at 24 h, but require 
40-48 h to appear (data not shown). Thus, there is ade- 
quate time for the earlier event of  cytolysis, which occurs 
within 4 h after exposure to antigen-pulsed targets, to take 
place before the ultimate death of the CTL at a later time 
point. 
Inhibition Can be Prevented by the Presence of Anti-TNF-ce 
Antibody. Recent evidence suggests that TNF-(x can me- 
diate apoptotic death of CD8 + T lymphocytes that are un- 
dergoing apoptotic death as a result of hyperengagement of 
the TCR of recently activated cells via ant i -TCR antibod- 
ies (15). To determine whether TNF-cl is involved in the 
inhibition observed in our cultures, an anti-TNF-cl  poly- 
clonal antibody was added to CTL stimulated with either 
high or low dose antigen-pulsed stimulators. As shown in 
Fig. 4, the presence of anti-TNF-c~ antibody restored the 
proliferative response of high avidity CTL stimulated with 
supraoptimal pept ide/MHC determinant density while 
having no effect on the response of the low avidity CTL 
line to the same stimulators. Fas cross-linking, shown in 
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Figure 3. The lack of a proliferative response by the high avidity CTL 
to high dose antigen is the result of apoptotic death. 4 d after routine 
stimulation, high and low avidity CTL were analyzed for apoptotic nuclei 
(A) or hypodiploid DNA (B) 45 h after exposure to high dose or low dose 
antigen. APC (Thy 1.2-depleted splenocytes) were either unpulsed (stip- 
pled bars), or pulsed with 0.001 ktM (striped bars), or 100 p~M (solid bars) 
peptide. For analysis ofapoptotic nuclei, CTL were identified by incuba- 
tion with biotinylated-Thy 1.2 and PE-avidin. Cells were then fixed, and 
Hoechst dye was added to view the nucleus. CTL were assessed for apop- 
totic nuclear morphology by fluorescence microscopy. As a control for 
residual free peptide, supematant from the final wash of the 100 p,M- 
pulsed APC was added at 1:1 in some wells with 0.001 p.M-pulsed APC 
and 14% of CTL contained apoptotic nuclei. For hypodiploid DNA anal- 
ysis, CTL were identified by incubation with FITC-conjugated antibody 
specific for Thy t.2. Propidium iodide was added for DNA detection. 
mult iple studies to induce death o f  T lymphocytes, does 
not appear to be involved in the inhibit ion and death under 
the condit ions tested here, since soluble anti-Fas antibody 
did not  restore the proliferative response o f  the high avidity 
CTL  (Fig. 4). 
Discussion 
This study reports the ability o f  high dose peptide anti- 
gen presented by APC to induce apoptotic death in a high 
avidity CD8 § CTL  line whi le maximally activating CTL  o f  
lower  avidity. This is the first report to document  a role for 
increasing peptide ligand presented by APC in the deletion 
o f  mature CD8 § CTL ,  as well  as the contr ibut ion o f  avid- 
ity in determining cell fate. These findings are distinct f rom 
previous studies o f  CD8 § CTL  in which  the effect o f  su- 
praoptimal TCR stimulation via antibody or purified al- 
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Neutralizing anti-TNF-a antibody can reverse the inhibi- Figure 4. 
tion obtained with supraoptimal peptide/MHC determinant density. 4 d 
after routine stimulation, high (A) and low (B) avidity CTL were assayed 
for proliferation resulting from stimulation with irradiated splenocytes 
pulsed with various concentrations ofpeptide antigen, as described in Fig. 
1 A. No antibody (stippled bars), neutralizing anti-TNF-er antibody, 1:50 
(solid bars), or Jo2 anti-Fas antibody (10 Ixg/ml; cross-hatched bars) was 
added to determine the role of these two molecules in the inhibition ob- 
served. In the case of the anti-Fas antibody, FcBlock (5 p~g/ml) was added 
to prevent possible cross-linking of the antibody by APC. (In other ex- 
periments, the presence of FcBlock alone did not affect he response.) No 
significant effect was observed in the presence of anti-Fas antibody. As a 
positive control for the function of the anti-Fas antibody, we tested its 
ability to inhibit lysis of Fas-expressing L1210 transfectants by the Fas 
ligand-expressing d11S CTL hybridoma (18). At a 15:1 E/T ratio, the 
anti-Fas antibody (10 p,g/ml) inhibited specific SlCr release from 78 + 
2% in the absence of antibody to 15 + 2%, in the presence of the antibody 
(81% inhibition). 
loantigen was not  assessed either with regard to the inde- 
pendent role o f  increasing peptide ligand density or with 
regard to the effects o f  such treatment on resting CTL  (31, 
33). The data presented in this study suggest hat the num-  
ber o f  peptide determinants presented by the APC regu- 
lates either positively or negatively the ability o f  CTL  to 
proliferate in response to antigen. H igh avidity CTL ,  capa- 
ble o f  being activated by a low number  o f  pept ide /MHC 
complexes, are deleted by exposure to APC with a very 
high density o f  pept ide /MHC complexes, whi le low avid- 
ity CTL  are maximally stimulated at this same high deter- 
minant density. 
The  ability o f  soluble ant i -CD8 Ab to restore the prolif- 
erative response o f  high avidity CTL  stimulated with 100 
p~M-pulsed APC suggests that the signal received by CTL 
is a summation of the interaction of a number of proteins, 
in this case, the TCR and CD8. If the combined signals 
from these two receptors reach a certain threshold, then 
cells are activated. If, however, the signal surpasses a higher 
threshold, above the range for activation, as is the case for 
high avidity CTL stimulated with APC pulsed with 100 
~M peptide, death will result, due at least in part to the re- 
lease of TNF-oc However, if the contribution of CD8 is 
blocked, then the lower level of signal generated results in 
CTL proliferation. In situations in which the number of 
peptide/MHC complexes i more limited, the level of sig- 
nal delivered from TCR binding alone is insufficient o 
reach the threshold required for activation, and signal am- 
plification via CD8 becomes amandatory part of the inter- 
action to stimulate proliferation. Thus, the engagement of
CD8 and TCR is critical both for positive and negative 
regulation of CTL. 
At first, the observed inhibition of the d4 CTL seems to 
be similar to the activation-induced death reported by oth- 
ers (14, 15, 31, 32, 34-38). It is thought hat death via this 
pathway depends on the reexposure of recently activated 
cycling cells to one of a variety of stimuli (8, 14, 31, 32, 
34-38). The inhibition of CD4 + cell proliferation at high 
antigen concentration may be the result of a second en- 
counter of the cells with antigen within 24 h of the initial 
stimulation, resulting in AICD (1, 14). 
The data presented here suggest that both resting and ac- 
tivated CD8 + CTL are equally susceptible to inhibition and 
apoptotic death by high concentrations of peptide antigen 
presented by MHC on the surface of APC. Similar to 
AICD, we observe apoptotic deletion in response to su- 
praoptimal peptide/MHC determinant density. Before the 
present report, this had not been reported for peptide-spe- 
cific, CD8 + CTL. In addition, we have demonstrated that 
the mediator of death is, at least in part, TNF-cx, in agree- 
ment with a recent study by Zheng et al. in which hetero- 
geneous populations of CD8 + lymph node T lymphocytes 
were stimulated with high doses of anti-CD3 antibody to 
induce AICD (15). In our study, the apoptotic death of the 
high avidity CTL line suggests that TNF-cx is produced 
only after stimulation with very high peptide/MHC deter- 
minant density or that high determinant density is required 
to achieve levels of TNF-~ production that are capable of 
inducing apoptotic death. Alternatively, the action of TNF-~x 
may be attributable to differential TNF-cx receptor egula- 
tion after stimulation with various antigen doses. Identifica- 
tion of TNF-cx as the mediator of the apoptotic signal is 
likely to be the explanation for the requirement of 40-48 h 
before apoptotic death is measurable after stimulation with 
high concentrations ofpulsed peptide antigen. Experiments 
are currently underway to determine whether this process 
is regulated by increased TNF-cx production or TNF-oL re- 
ceptor upregulation or both. 
Although the above similarities exist, several important 
differences from AICD are apparent. First, Fas and Fas 
ligand, which have been suggested to mediate classical 
AICD (39), do not play a role here (Fig. 4). Second, our 
data demonstrate hat high avidity, activated 4 CTL ,  and 
resting dl l  CTL require 40-48 h for the appearance of 
apoptotic nuclei. As discussed above, for AICD to occur, 
resting CD4 + cells are thought o require two distinct acti- 
vation encounters with antigen, and it is the second en- 
gagement by the now cycling cell that is responsible for 
triggering death. Experiments with dl 1 CTL used in this 
study, in which 100 btM-pulsed APC were removed after 
9 h of exposure and the CTL were replated in the presence 
of unpulsed APC, demonstrated that the commitment to 
death has already occurred during this initial antigenic en- 
counter, suggesting that these CTL do not require a second 
encounter with antigen while cycling to induce apoptosis 
(data not shown). The only precedent for inhibition and 
apoptosis resulting from a single encounter with antigen is 
in the nonphysiological case of T cell hybridomas (40). 
Moreover, the same concentration of peptide is required 
for the deletion of both recently activated and resting CTL 
(Figs. 1 A and 2 A). Thus, there is no evidence that actively 
cycling CD8 + CTL ceils are more predisposed or sensitive 
to supraoptimal TCR engagement for induction of apop- 
totic death. Finally, as noted previously, proliferation of the 
CTL in response to high dose antigen is inhibited from the 
very beginning of the culture, as determined by a pulse 
with [3H]thymidine between 0-24 h after initiation of the 
culture. Together, these data support the hypothesis that 
the signal resulting in apoptosis of resting CTL is a result of 
the first antigenic stimulation with supraoptimal detemai- 
nant density. These data argue that the strength of signal is 
much more important in determining the outcome of 
TC1L engagement by CD8 + CTL effector lines than is the 
activation state of the ceils prior to encounter with pep- 
tide/MHC. 
Several studies have shown that CTL-CTL  presentation 
ofpeptide can cause inhibition oflytic function, anergy, or 
death (26-30). However results obtained using T cell- 
depleted APC or addition of control supernatant from the 
final wash of 100 I~M-pulsed APC rule out the possibility 
o fT  cell-T cell antigen presentation or free peptide inhibi- 
tion in our system. 
The data presented herein may help explain results by 
Moskophidis et al., which suggest that CTL capable of viral 
clearance undergo deletion as a result of clonal exhaustion 
after challenge with large doses of virus (12). Under such 
circumstances, viral antigen may be either constitutively 
presented for extended periods of time or presented at an 
increased level at the cell surface on a per cell basis. Our re- 
suits suggest hat the latter would result in the deletion of 
high avidity CTL, which are more effective for viral clear- 
ance, leaving only low avidity CTL inadequate to control 
viral spread (16, 41). Moreover, it has been demonstrated 
that during the course of HIV-1 infection, there is an on- 
going loss of HIV-specific CD8 + T cells (42). Given the 
viral load attained during HIV-1 infection, it is possible 
that a determinant density is achieved which is capable of 
inducing deletion of the virus-specific ells, in a manner 
analogous to the deletion reported in this study. 
Our previous finding (16) that only low avidity CTL are 
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expanded under conditions of  high dose antigen are ex- 
plained by the data presented here. Under such conditions, 
high avidity cells would undergo apoptosis as a result ofsu-  
praoptimal engagement of  the TCR,  and thus be deleted 
from the line. 
In conclusion, the delivery of  an activating signal to 
CTL is complex and several proteins are likely to contrib- 
ute. Preeminent among these are the TCR and CD8. The 
number of  pept ide/MHC complexes required for optimal 
TCR engagement is a function of  the inherent require- 
ments of  the CTL in that there is a specific range of  deter- 
minant densities that is acceptable for activation and con- 
centrations of  ligand that exceed this range will induce 
deletion of  the CTL, mediated at least in part by the pro- 
duction of  TNF-c~, and not by Fas-FasL interaction. In ad- 
dition, susceptibility to high dose inhibition by the CTL is 
not restricted to recently activated cells. The deletion re- 
ported here may contribute to high zone tolerance and/or 
clonal exhaustion, and loss ofHIV-specific CTL during pro- 
gression toward AIDS. Moreover, this knowledge may 
have implications for therapy ofautoimmune diseases or al- 
lograft rejection. 
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